Medicine and Dentistry
Glioblastoma
100%
Aspartic Acid
100%
Cilengitide
100%
Integrin
100%
Arginine
100%
External Beam Radiotherapy
25%
Clinical Trial
25%
Angiogenesis
12%
Temozolomide
12%
Tumor Invasion
12%
Cytotoxic Chemotherapy
12%
Cell Survival
12%
Tumor Vascularization
12%
Vascular Cancer
12%
Arm
12%
Keyphrases
Glioblastoma multiforme
100%
Arginine-glycine-aspartic Acid
100%
Cilengitide
100%
Integrin Targeting
100%
Clinical Trials
25%
External Beam Radiotherapy
25%
Angiogenesis
12%
Clinical Experience
12%
Integrin
12%
Antitumor
12%
Cell Survival
12%
Synergize
12%
Cytotoxic Therapy
12%
Temozolomide
12%
Newly Diagnosed Glioblastoma
12%
Randomized Phase III Trial
12%
Tumor Vasculature
12%
Single-arm Study
12%
Survival Migration
12%
Recurrent Glioblastoma multiforme
12%
Integrin Antagonist
12%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
Integrin
100%
Cilengitide
100%
Aspartic Acid
100%
Arginine
100%
Clinical Trial
25%
Preclinical Study
12%
Cytotoxic Chemotherapy
12%
Tumor Invasion
12%
Tumor Vascularization
12%
Temozolomide
12%
Vascular Cancer
12%